Plasma Fractionation Market by Type (Albumin, Coagulation Factor Concentrates, Immunoglobulins, Protease Inhibitors), Application, End User, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2029

Plasma Fractionation Market Size

The Plasma Fractionation market size was valued at $29.36 billion in 2023 and is projected to reach $44.56 billion by 2029, growing at a CAGR of 7.2% during the forecast period.

Plasma Fractionation Market Overview

Plasma fractionation is a complex biochemical process used to separate and purify various components of blood plasma into specific protein fractions. This process involves the fractionation of plasma proteins, such as immunoglobulins, albumin, clotting factors, and other plasma-derived proteins, through a series of separation and purification steps. These steps typically include techniques such as precipitation, chromatography, filtration, and centrifugation, which isolate and purify individual proteins based on their molecular size, charge, or affinity. Plasma fractionation plays a crucial role in the production of therapeutic products such as immunoglobulins, coagulation factors, and albumin, which are used to treat a wide range of medical conditions, including immune deficiencies, bleeding disorders, and certain neurological disorders. These plasma-derived products are essential for medical treatment and are subject to stringent quality control measures to ensure safety, efficacy, and compliance with regulatory standards. Plasma fractionation is a vital process in the biopharmaceutical industry, providing life-saving therapies for patients worldwide.

Plasma Fractionation Market Dynamics

The market dynamics analyzed in this market research report encapsulate a multifaceted interplay of drivers and constraints that significantly shape the landscape of the Plasma Fractionation Market. The comprehensive analysis of both drivers and constraints enables a nuanced understanding of the market's dynamics, empowering businesses and stakeholders to make informed decisions in navigating the complexities of the market.

Plasma Fractionation Market Scope

The report “Global Plasma Fractionation Market: Industry Analysis, Opportunities and Forecast up to 2029” by Diligence Insights provides a detailed analysis of the present market and future outlook with market estimates and forecasts for all specified segments, encompassing both global and regional perspectives as outlined within the research framework. The study includes historical market data for the years 2021, 2022 and offers revenue estimations for 2023, and project forecasts spanning from 2024 to 2029. It places significant emphasis on the examination of market trends, key industry participants, supply chain developments, technological advancements, pivotal milestones, and prospective strategies. Comprehensive market assessments are carried out across major geographic regions, including North America, Europe, Asia Pacific, South America, and Middle East & Africa. As such, this report constitutes a valuable resource for current industry stakeholders, newcomers to the field, and potential investors.

The study offers an in-depth market analysis, drawing insights from industry experts across the value chain. A special focus has been made on 25 countries, including the United States, Canada, Mexico, the United Kingdom, Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, and South Africa, among others. The market data has been meticulously collected through extensive primary interviews and comprehensive secondary research. Market size determination is rooted in the revenue generated from sales across all the specified segments and sub-segments as defined within the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

Market Segmentation:

The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Global Plasma Fractionation Market by, Type

·        Albumin

·        Coagulation Factor Concentrates

·        Immunoglobulins

·        Protease Inhibitors

·        Other Types

Global Plasma Fractionation Market by, Application

·        Neurology

·        Immunology

·        Hematology

·        Other Applications

Global Plasma Fractionation Market by, End User

·        Academic Institutes

·        Clinical Research Laboratories

·        Hospitals & Clinics

Global Plasma Fractionation Market by, Geography

·        North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis.

·        Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis

·        Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis

·        South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis

·        Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis.

Key Players Profiled in this Research Report include:

·        Bio Product Laboratory

·        Biotest AG 

·        CSL Limited

·        Grifols, S.A.

·        Kedrion S.P.A

·        Octapharma AG

·        Sanquin

·        Shire Plc.

·        The LFB Group

What can be explored with this research report?

·        Understand global Plasma Fractionation Market analysis, trends, and forecast to 2029.

·        Understand analysis of the Plasma Fractionation Market structure by identifying various segments and sub-segments of the market.

·        Understand revenue forecast and strategic analysis concerning industry trends and contribution to the overall Plasma Fractionation Market.

·        Understand the revenue forecast of the Plasma Fractionation Market for North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

·        Identification of major market trends, factors driving, restraining, threatening, and providing opportunities for the Plasma Fractionation Market growth.

·        Analyzing opportunities by identification of high-growth segments/revenue pockets in the Plasma Fractionation Market.

·        Understand major player profiles in the Plasma Fractionation Market and analyze their business strategies.

·        Understand competitive developments such as joint ventures, alliances, mergers and acquisitions, and new product launches in the Plasma Fractionation Market.

Table Of Content

1 Market Introduction 
 1.1 Market Definition 
 1.2 Research Scope and Segmentation 
 1.3 Stakeholders 
 1.4 List of Abbreviations 
 
2 Executive Summary 
 
3 Research Methodology 
 3.1 Identification of Data 
 3.2 Evaluation of Market Dynamics 
 3.3 Collaboration of Data 
 3.4 Verification and Analysis 
 3.5 Research Approach 
 3.6 Data Sources and Assumptions 
 
4 Market Dynamics 
 4.1 Market Drivers 
 4.2 Market Restraints 
 4.3 Market Opportunities 
 4.4 Market Challenges 
 4.5 Impact of COVID-19 on the Plasma Fractionation Market 
 
5 Porter's Five Force Analysis 
 5.1 Bargaining Power of Suppliers 
 5.2 Bargaining Power of Buyers 
 5.3 Threat of New Entrants 
 5.4 Threat of Substitutes 
 5.5 Competitive Rivalry in the Market 
 
6 Global Plasma Fractionation Market by, Type 
 6.1 Overview 
 6.2 Albumin 
 6.3 Coagulation Factor Concentrates 
 6.4 Immunoglobulins 
 6.5 Protease Inhibitors 
 6.6 Other Types 
 
7 Global Plasma Fractionation Market by, Application 
 7.1 Overview 
 7.2 Neurology 
 7.3 Immunology 
 7.4 Hematology 
 7.5 Other Applications 
 
8 Global Plasma Fractionation Market by, End User 
 8.1 Overview 
 8.2 Academic Institutes 
 8.3 Clinical Research Laboratories 
 8.4 Hospitals & Clinics 
 
9 Global Plasma Fractionation Market by, Geography 
 9.1 Overview 
 9.2 North America 
 9.2.1 US 
 9.2.2 Canada 
 9.2.3 Mexico 
 9.3 Europe 
 9.3.1 Germany 
 9.3.2 France 
 9.3.3 UK 
 9.3.4 Italy 
 9.3.5 Spain 
 9.3.6 Rest of Europe 
 9.4 Asia Pacific 
 9.4.1 China 
 9.4.2 Japan 
 9.4.3 India 
 9.4.4 South Korea 
 9.4.5 Australia 
 9.4.6 New Zealand 
 9.4.7 Rest of Asia Pacific 
 9.5 South America 
 9.5.1 Brazil 
 9.5.2 Argentina 
 9.5.3 Chile 
 9.5.4 Rest of South America 
 9.6 Middle East & Africa 
 9.6.1 UAE 
 9.6.2 Saudi Arabia 
 9.6.3 Qatar 
 9.6.4 Iran 
 9.6.5 South Africa 
 9.6.6 Rest of Middle East & Africa 
 
10 Key Developments 
 
11 Company Profiling 
 11.1 Bio Product Laboratory 
 11.1.1 Business Overview 
 11.1.2 Product/Service Offering 
 11.1.3 Financial Overview 
 11.1.4 SWOT Analysis 
 11.1.5 Key Activities 
 11.2 Biotest AG   
 11.3 CSL Limited  
 11.4 Grifols, S.A.  
 11.5 Kedrion S.P.A  
 11.6 Octapharma AG  
 11.7 Sanquin  
 11.8 Shire Plc.  
 11.9 The LFB Group